![]() Pluri Biotech Pluri Biotech (פלורי ביוטק בע"מ, formerly Pluristem Therapeutics) is a clinical-stage biotherapy company developing cell therapies. | Brainlab Brainlab is a company that develops, manufactures, and markets software-driven medical technology. | ||||
Founding Date | Founding Date 2000 | Founding Date 2003 | Founding Date 1989 | Founding Date 2014 | Founding Date 2016 |
Type | Type Private | Type Public | Type Private | Type Public | Type Private |
Tags | |||||
Locations | Locations Treize-Septiers, FR HQ | Locations Haifa, IL HQ Potsdam, DE | Locations Munich, DE HQ Melbourne, AU Sydney, AU São Paulo, BR Beijing, CN Paris, FR Heidelberg, DE see more | Locations HQ | Locations Cambridge, GB HQ |
Employees | Employees 122 | Employees 106 | Employees 1,9839% decrease | Employees N/A | Employees 3014% decrease |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $1.3m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) kr630k (FY, 2024) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $682k (FY, 2025) | Cost of goods N/A | Cost of goods kr522k (FY, 2024) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $654k (FY, 2025) | Gross profit N/A | Gross profit kr1.2m (FY, 2024) | Gross profit N/A |
Net income | Net income N/A | Net income ($23.3m) (FY, 2025) | Net income N/A | Net income (kr10.7m) (FY, 2024) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 7.3m (over 19 years ago) | Latest funding round N/A | Latest funding round $ 17m (about 5 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 78.4m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 36.7m |

Pluri Biotech (פלורי ביוטק בע"מ, formerly Pluristem Therapeutics) is a clinical-stage biotherapy company developing cell therapies.
View companyBrainlab is a company that develops, manufactures, and markets software-driven medical technology.
View company
Audientes is a biotechnology company that develops treatments for muscle diseases.
View company
Mogrify is a biotech company advancing cell therapies.
View company